The U.S. Food and Drug Administration on Wednesday approved the first fecal microbiota treatment, aimed at helping adults battling tough-to-treat Clostridium difficile (C. diff)infections.
Stress affects gut health and intensifies pain, which — for people with irritable bowel syndrome (IBS) — can make traveling to see family during the holiday season excruciating.